April will see the first of five Focused Meetings (SAM 2014, FAAM 2014, ISAF 2014 and EuroBAT 2014) take place, with the 6th Drug Hypersensitivity Meeting, DHM 2014, held in Bern, Switzerland from 9 – 12 April. This is alongside our main event of the year, the Annual Congress, as well as four Allergy Schools. To say 2014 is a busy one for EAACI would be distinctly underselling it.

These events, alongside the numerous internal meetings that are peppered across the calendar year, form the core purpose for the existence of the Academy; to help improve the lives of allergy and asthma sufferers on a global scale.

Education, research and keeping abreast of the most up-to-date research is vital for physicians and other medical professionals to keep ahead of the curve. In my Strategic Programme I indicate that to maintain state-of-the-art scientific content we need to “continue working towards accurate identification of the best presenters of the most novel and relevant scientific findings.” This is what we try to provide through all of the academy’s initiatives, and is something I feel has continued to improve over the last few years.

It is for this reason that we create publications such as Clinical Translational Allergy and encourage physicians to publish and cite from it. Last month it was announced that EAACI will offer discounted article processing charges for manuscripts (10 50% discounts for JMAs and up to 50 10% discounts for full EAACI members) so now is the time to utilise this valuable resource and publish relevant findings in an up-and-coming journal. Over 13,000 accesses were made in January 2014, reflecting the considerable scope of open-access publishing for widespread dissemination of information to a world-wide audience.

Additionally, it is the motive behind enterprising schemes such as the Fellowship Awards. The 2014 winners have now been announced and the details are available online. Congratulations to all those who successfully applied. JMAs form the future of this Academy and it is through arrangements like the Fellowships or the JMA Mentorship Programme that we nurture their development.

However, we cannot rest on our laurels and must continue in an innovative and adaptable manner. There are many ways we can do this, but I encourage you, our membership as well as past and future attendees to our events, to help inform us on how we can improve as an organisation. We want to deliver the best possible service and can only do that on the back of your constructive feedback.

Register for DHM 2014, SAM 2014, FAAM 2014, ISAF 2014, EuroBAT 2014 or any of our Allergy Schools. If you’re a member, attend the General Assembly at the Annual Congress and participate in the decision-making process. With knowledge comes enlightenment, and only through this can we begin to create the tools to further the ambitions we already have.

Thank you for your ongoing support and engagement with the Academy.
Nikos Papadopoulos
EAACI President
Last updated 27 November 2014
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Send feedback